1071 - 1080 of 7877 Results
Title
Year
- Predicting longitudinal brain atrophy in Parkinson’s disease using a Susceptible-Infected-Removed agent-based model2022OPENTitle: Predicting longitudinal brain atrophy in Parkinson’s disease using a Susceptible-Infected-Removed agent-based modelJournal Name: Network NeurosciencePublisher: MIT PressVol: 7Issue #: 3Start Page: 906End Page: 925Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1162/netn_a_00296Best OA location URL: https://direct.mit.edu/netn/article-pdf/doi/10.1162/netn_a_00296/2074404/netn_a_00296.pdfCitation Count: 7
-
RESTRICTEDTitle: Progressive Supranuclear Palsy Syndrome Associated With a Novel TauopathyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page: 1094End Page: 1098Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201485Citation Count: 5
- Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study2022OPENTitle: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort StudyJournal Name: Diabetes CarePublisher: American Diabetes AssociationVol: 46Issue #: 2Start Page: 297End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2337/dc22-1705Best OA location URL: https://diabetesjournals.figshare.com/articles/figure/Association_of_sodium-glucose_cotransporter-2_inhibitors_with_time_to_dementia_a_population-based_cohort_study/21445284/1/files/38063811.pdfCitation Count: 43
-
OPENTitle: Isolated Jaw and Tongue Tremor in a Definite Case of Progressive Supranuclear PalsyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 348End Page: 349Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13640Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13640Citation Count: 0
-
RESTRICTEDTitle: LRRK2-targeted Parkinson disease drug advances into phase IIIJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/d41573-022-00212-0Citation Count: 8
- Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networks2022OPENTitle: Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networksJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-25454-1Best OA location URL: https://www.nature.com/articles/s41598-022-25454-1.pdfCitation Count: 2
-
OPENTitle: The genetic regulation of protein expression in cerebrospinal fluidJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.202216359Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202216359Citation Count: 21
- Video-Based Facial Movement Analysis in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Clinical Validation2022OPENTitle: Video-Based Facial Movement Analysis in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Clinical ValidationJournal Name: Journal of Speech, Language, and Hearing ResearchPublisher: American Speech Language Hearing AssociationVol: 65Issue #: 12Start Page: 4667End Page: 4678Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1044/2022_jslhr-22-00072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940890Citation Count: 11
- Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete Recovery2022OPENTitle: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete RecoveryJournal Name: Annals of Otology, Rhinology & LaryngologyPublisher: SAGE PublicationsVol: 132Issue #: 10Start Page: 1177End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/00034894221138485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742352Citation Count: 2
- It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum2022OPENTitle: It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid SumJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 342End Page: 347Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29279Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974855Citation Count: 9